Global burden of cancers attributable to infections in 2012: a synthetic analysis

The Lancet Global Health

Volumn 4, Issue 9, 2016, Pages e609-e616

  Plummer, Martyn ^a   de Martel, Catherine ^a   Vignat, Jerome ^a   Ferlay, Jacques ^a   Bray, Freddie ^a   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CARDIA CARCINOMA; CLONORCHIS SINENSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; INFECTION; KAPOSI SARCOMA; LIVER CANCER; META ANALYSIS (TOPIC); MIXED INFECTION; NEOPLASM; OPISTHORCHIS VIVERRINI; PENIS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHISTOSOMA HAEMATOBIUM; SYSTEMATIC REVIEW (TOPIC); WART VIRUS; BACTERIAL INFECTION; GLOBAL HEALTH; MICROBIOLOGY; PREVALENCE; RISK FACTOR; VIRUS INFECTION;

BACTERIAL INFECTIONS; GLOBAL HEALTH; HUMANS; NEOPLASMS; PREVALENCE; RISK FACTORS; VIRUS DISEASES;

EID: 84996606587     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(16)30143-7     Document Type: Article

References (33)

1. 1 de Martel, C, Ferlay, J, Franceschi, S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13 (2012), 607–615.
2. 2 Parkin, DM, The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 (2006), 3030–3044.
3. 3 Pisani, P, Parkin, DM, Munoz, N, Ferlay, J, Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6 (1997), 387–400.
4. 4 Ferlay, J, Soerjomataram, I, Ervik, M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase no. 11, 2013, International Agency for Research on Cancer, Lyon http://GLOBOCAN.iarc.fr (accessed May 12, 2015).
5. 5 IARC. Biological agents. IARC Monogr Eval Carcinog Risks Hum 100B (2012), 1–475 http://monographs.iarc.fr/ENG/Monographs/vol100B/index.php (accessed May 12, 2015).
6. 6 de Martel, C, Shiels, MS, Franceschi, S, et al. Cancers attributable to infections among adults with HIV in the United States. AIDS 29 (2015), 2173–2181.
7. 7 IARC Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for preventing gastric cancer. IARC Working Group Reports No. 8, 2014, International Agency for Research on Cancer, Lyon, France https://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php (accessed May 18, 2015).
8. 8 Combes, JD, Franceschi, S, Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 50 (2014), 370–379.
9. INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 15 (2014), 1319–1331.
10. 10 Plummer, M, Franceschi, S, Vignat, J, Forman, D, de Martel, C, Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer 136 (2015), 487–490.
11. 11 de Martel, C, Maucort-Boulch, D, Plummer, M, Franceschi, S, Worldwide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 62 (2015), 1190–1200.
12. 12 Human Development Report 2013: the rise of the south: human progress in a diverse world, 2013, UN Development Program, New York http://hdr.undp.org/en/2013-report (accessed May 20, 2015).
13. 13 Human Development Report 2015: work for human development, 2015, UN Development Program, New York http://hdr.undp.org/en/2015-report (accessed May 20, 2015).
14. 14 Roberts, CP, Casella, G, Monte Carlo statistical methods, 2004, Springer-Verlage, New York.
15. 15 WHO. Global status report on noncommunicable diseases 2010. Annex 5: core indicators for consideration as part of the framework for NCD surveillance, 2011, World Health Organization, Geneva.
16. 16 Shin, HR, Shin, A, Woo, H, et al. Prevention of infection-related cancers in the WHO western Pacific region. Jpn J Clin Oncol 46 (2016), 13–22.
17. 17 Bruggmann, P, Berg, T, Ovrehus, AL, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 21:suppl 1 (2014), 5–33.
18. 18 Crosbie, EJ, Einstein, MH, Franceschi, S, Kitchener, HC, Human papillomavirus and cervical cancer. Lancet 382 (2013), 889–899.
19. 19 Robey, RC, Bower, M, Facing up to the ongoing challenge of Kaposi's sarcoma. Curr Opin Infect Dis 28 (2015), 31–40.
20. 20 Lee, JH, Kim, Y, Choi, JW, Kim, YS, Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin's lymphoma: a meta-analysis. Arch Med Res 45 (2014), 417–431.
21. 21 Bray, F, Jemal, A, Grey, N, Ferlay, J, Forman, D, Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol 13 (2012), 790–801.
22. 22 Shimakawa, Y, Bah, E, Wild, CP, Hall, AJ, Evaluation of data quality at the Gambia national cancer registry. Int J Cancer 132 (2013), 658–665.
23. 23 Smith, BD, Beckett, GA, Yartel, A, Holtzman, D, Patel, N, Ward, JW, Previous exposure to HCV among persons born during 1945–1965: prevalence and predictors, United States, 1999–2008. Am J Public Health 104 (2014), 474–481.
24. 24 WHO. Global immunization data 2015, 2015, World Health Organization, Geneva http://www.who.int/immunization/monitoring_surveillance/Global_Immunization_Data.pdf (accessed Nov 23, 2015).
25. 25 Hung, GY, Horng, JL, Yen, HJ, Lee, CY, Lin, LY, Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan. J Hepatol 63 (2015), 1390–1396.
26. 26 WHO Publication. Hepatitis B vaccines: WHO position paper—recommendations. Vaccine 28 (2010), 589–590.
27. 27 Hanson, CM, Eckert, L, Bloem, P, Cernuschi, T, Gavi HPV programs: application to implementation. Vaccines (Basel) 3 (2015), 408–419.
28. 28 Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec 89 (2014), 465–491.
29. 29 WHO. WHO guidelines approved by the Guidelines Review Committee. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection, 2015, World Health Organization, Geneva.
30. 30 Bohlius, J, Valeri, F, Maskew, M, et al. Kaposi's sarcoma in HIV-infected patients in South Africa: multicohort study in the antiretroviral therapy era. Int J Cancer 135 (2014), 2644–2652.
31. 31 WHO. Policy brief: consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: what's new, 2015, World Health Organization, Geneva http://www.who.int/iris/handle/10665/198064 (accessed June 15, 2016).
32. 32 Clifford, GM, de Vuyst, H, Tenet, V, Plummer, M, Tully, S, Franceschi, S, Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa. J Acquir Immune Defic Syndr, 2016, 10.1097/QAI.0000000000001113 published online June 15.
33. 33 Herrero, R, Park, JY, Forman, D, The fight against gastric cancer—the IARC Working Group report. Best Pract Res Clin Gastroenterol 28 (2014), 1107–1114.